|
RP
MCID: RTN008
|
Retinitis Pigmentosa malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 33OMIM, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the light-sensitive part of the eye (retina). RP causes cells in the retina to breakdown and die, eventually resulting in vision loss. The first sign of RP is usually night blindness. As the condition progresses, affected individuals also develop tunnel vision. Sometimes RP occurs by itself (isolated RP), and other times it occurs with additional signs and symptoms (syndromic RP). Mutations in at least 50 genes have been found to cause RP. There is no cure for RP, however, there are a few treatment options to slow down the progression of the disease. These options include light avoidance, use of low-vision aids, and vitamin A supplementation.30
MalaCards: Retinitis Pigmentosa, also known as retinitis pigmentosa 1, is related to retinitis and usher syndrome. An important gene associated with Retinitis Pigmentosa is RPGR (retinitis pigmentosa GTPase regulator), and among its related pathways are Visual Cycle in Retinal Rods and Phototransduction. The compounds serine and lipid have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, whole blood and retina, and related mouse phenotypes are vision/eye and endocrine/exocrine gland. Genetics Home Reference: Retinitis pigmentosa is a group of related eye disorders that cause progressive vision loss. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with retinitis pigmentosa, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.17 OMIM: 180100 |
|
Sources: 6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 33OMIM, 32Novoseek , 43UMLS, 40SNOMED-CT, 27NCIt, 24MeSH See all sources |
Aliases & Descriptions:
External Ids:
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 180100
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 21LifeMap Discovery™, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for retinitis pigmentosa Drug clinical trials:Search ClinicalTrials for retinitis pigmentosa Search NIH Clinical Center for retinitis pigmentosa Search CenterWatch for retinitis pigmentosa Cell-based therapeutics:![]() The database of embryonic development, stem cell research and regenerative medicine Stem-Cell-Based therapeutic approaches for retinitis pigmentosa:
|
|
|
|
Sources: 21LifeMap Discovery™, 22MalaCards See all sources |
MalaCards organs/tissues related to retinitis pigmentosa:22Bone marrow, Whole blood, Retina, Skin, T cells, B cells ![]() The database of embryonic development, stem cell research and regenerative medicine Embryonic and adult cells/anatomical compartments related to retinitis pigmentosa:
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to retinitis pigmentosa:25 (show all 14)
|
|
Sources: 35PubMed See all sources |
Articles related to retinitis pigmentosa:(show top 50) (show all 606)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 36QIAGEN, 20KEGG, 10EMD Millipore, 41Thomson Reuters See all sources |
Pathways related to retinitis pigmentosa according to GeneDecks:
|
|
Sources: 32Novoseek , 18HMDB, 42Tocris Bioscience, 9DrugBank See all sources |
Compounds related to retinitis pigmentosa according to GeneDecks:(show all 29)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to retinitis pigmentosa according to GeneDecks:(show all 15)
Biological processes related to retinitis pigmentosa according to GeneDecks:(show all 23)
Molecular functions related to retinitis pigmentosa according to GeneDecks:
|

